Showing results (531-540 of 1,892) with videos related to

Sort By:
Pageof 190
Immunotherapy|May 8, 2020
Efficacy of immune checkpoint inhibitors and age in cancer patientsXuan-Zhang Huang, Peng Gao, Yong-Xi Song, et al.
Immunotherapy|April 23, 2020
PD-1 blockade for disseminated Kaposi sarcoma in a patient with atopic dermatitis and chronic CD8 lymphopeniaThilo Gambichler, Laura Susok
Immunotherapy|April 9, 2020
Not just 'immunity': how the microbiota can reshape our approach to cancer immunotherapyFederico Boem, Giulia Nannini, Amedeo Amedei
Immunotherapy|August 13, 2021
Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature reviewSeda Hanife Oğuz, Uğur Ünlütürk, Sercan Aksoy, et al.
Immunotherapy|August 25, 2021
Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysisWenwei Qian, Ying Ye, Lugen Zuo, et al.
Immunotherapy|November 17, 2021
Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group)Melissa Bersanelli, Giulia Mazzaschi, Patrizia Giannatempo, et al.
Immunotherapy|November 17, 2021
Immunomodulation with β-glucan from Pleurotus ostreatus in patients with endocrine-dependent breast cancerJan Spacek, Michal Vocka, Eva Zavadova, et al.
Immunotherapy|December 21, 2021
Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseasesRichard L Wasserman, Sudhir Gupta, Mark Stein, et al.
Immunotherapy|December 1, 2021
How bilastine is used to treat allergic rhinitis and urticaria in childrenPablo Rodríguez Del Río, Fernando Rodríguez Fernández, Esther Ballester Asensio, et al.
Immunotherapy|December 6, 2021
An update on the adalimumab biosimilar landscape following the approval of the first high-concentration biosimilarEnrico Fusaro, Patrick Durez, Johannes Wohlrab, et al.
Pageof 190